0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation |  FREE ONLINE FIRST
Jayashri Kulkarni, MBBS, PhD; Emorfia Gavrilidis, BAppSc; Stella M. Gwini, MSc; et al.
JAMA Psychiatry. Published online July 20, 2016. doi:10.1001/jamapsychiatry.2016.1383
Includes: Supplemental Content

Editorial |  ONLINE FIRST
Jan Volavka, MD, PhD
JAMA Psychiatry. Published online July 13, 2016. doi:10.1001/jamapsychiatry.2016.1348

Original Investigation |  ONLINE FIRST
Amir Sariaslan, PhD; Paul Lichtenstein, PhD; Henrik Larsson, PhD; et al.
JAMA Psychiatry. Published online July 13, 2016. doi:10.1001/jamapsychiatry.2016.1349
Includes: Supplemental Content

Original Investigation | 
Elaine H. Morrato, DrPH, MPH; Elizabeth J. Campagna, MS; Sarah E. Brewer, MPA; et al.
JAMA Psychiatry. 2016;73(7):721-730. doi:10.1001/jamapsychiatry.2016.0538.
Includes: Supplemental Content

Editorial | 
Joseph T. Coyle, MD; Glenn Konopaske, MD
JAMA Psychiatry. 2016;73(7):649-650. doi:10.1001/jamapsychiatry.2016.0575.

Original Investigation | 
Kate Merritt, MSc; Alice Egerton, PhD; Matthew J. Kempton, PhD; et al.
JAMA Psychiatry. 2016;73(7):665-674. doi:10.1001/jamapsychiatry.2016.0442.
Includes: Supplemental Content

Editorial | 
Daphne J. Holt, MD, PhD
JAMA Psychiatry. 2016;73(6):555-556. doi:10.1001/jamapsychiatry.2016.0172.

Original Investigation | 
Hengyi Cao, MB, MMedSc; Alessandro Bertolino, MD, PhD; Henrik Walter, MD, PhD; et al.
JAMA Psychiatry. 2016;73(6):598-605. doi:10.1001/jamapsychiatry.2016.0161.
Includes: Supplemental Content

Original Investigation | 
Theodore D. Satterthwaite, MD, MA; Daniel H. Wolf, MD, PhD; Monica E. Calkins, PhD; et al.
JAMA Psychiatry. 2016;73(5):515-524. doi:10.1001/jamapsychiatry.2015.3463.
Includes: Supplemental Content

Original Investigation | 
Divya Mehta, PhD; Felix C. Tropf, MSc; Jacob Gratten, PhD; et al.
JAMA Psychiatry. 2016;73(5):497-505. doi:10.1001/jamapsychiatry.2016.0129.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
News From the Food and Drug Administration  | 
Olanzapine Linked With Potentially Fatal Skin Reaction
Rebecca Voelker, MSJ
JAMA
News From the Food and Drug Administration  | 
Antipsychotic Drug May Cause Impulse-Control Problems
Rebecca Voelker, MSJ
JAMA Neurology
Editorial  | 
Antipsychotics and Increased Mortality Are We Sure?
Mark S. Baron, MD
JAMA Neurology
Original Investigation  | 
Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease
Daniel Weintraub, MD; Claire Chiang, PhD; Hyungjin Myra Kim, ScD; et al.